Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1996-03-05
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514375, 514408, 514411, 514422, 514423, A01N 4336, A01N 4338, A01N 4376, A61K 3140
Patent
active
054968372
ABSTRACT:
A method for treating a human or non-human animal afflicted with malignant cells sensitive to parabactin or a pharmaceutically acceptable salt or complex thereof comprising administering to the animal an amount of parabactin effective to inhibit the proliferation of the malignant cells.
REFERENCES:
patent: 5128353 (1992-07-01), Bergeron
patent: 5173505 (1992-12-01), Bergeron
patent: 5292775 (1994-03-01), Bergeron
patent: 5391563 (1995-02-01), Bergeron
Clarke Dennis P.
Nutter Nathan M.
University of Florida Research Foundation Inc.
LandOfFree
Anti-neoplastic anti-viral and ribonucleotide reductase activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-neoplastic anti-viral and ribonucleotide reductase activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-neoplastic anti-viral and ribonucleotide reductase activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1413159